Efficacy of propofol-based anesthesia against risk of brain swelling during craniotomy: A meta-analysis of randomized controlled studies.

Autor: Liu CC; Department of Anesthesiology, E-Da Hospital, I-Shou University, Kaohsiung City, Taiwan; Department of Nursing, College of Medicine, I-Shou University, Kaohsiung City, Taiwan; School of Medicine, I-Shou University, Kaohsiung City, Taiwan., Chen IW; Department of Anesthesiology, Chi Mei Medical Center, Liouying, Tainan City, Taiwan., Liu PH; Department of Anesthesiology, E-Da Dachang Hospital, I-Shou University, Kaohsiung City, Taiwan., Wu JY; Department of Nutrition, Chi Mei Medical Center, Tainan City, Taiwan., Liu TH; Department of Psychiatry, Chi Mei Medical Center, Tainan City, Taiwan., Huang PY; Department of Internal Medicine, Chi Mei Medical Center, Tainan City, Taiwan., Yu CH; Department of Anesthesiology, Chi Mei Medical Center, Tainan City, Taiwan., Fu PH; Department of Anesthesiology, Chi Mei Medical Center, Tainan City, Taiwan., Hung KC; Department of Anesthesiology, Chi Mei Medical Center, Tainan City, Taiwan; School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan. Electronic address: ed102605@gmail.com.
Jazyk: angličtina
Zdroj: Journal of clinical anesthesia [J Clin Anesth] 2024 Feb; Vol. 92, pp. 111306. Date of Electronic Publication: 2023 Oct 24.
DOI: 10.1016/j.jclinane.2023.111306
Abstrakt: Study Objective: This meta-analysis aimed to compare the risk of brain swelling during craniotomy between propofol-based and volatile-based anesthesia.
Design: Meta-analysis of randomized controlled trials (RCTs).
Setting: Operating room.
Intervention: Propofol-based anesthesia.
Patients: Adult patients undergoing craniotomy.
Measurements: Databases, including EMBASE, MEDLINE, Google Scholar, and Cochrane Library, were searched from inception to April 2023. The primary outcome was the risk of brain swelling, while the secondary outcomes included the impact of anesthetic regimens on surgical and recovery outcomes, as well as the risk of hemodynamic instability.
Main Results: Our meta-analysis of 17 RCTs showed a significantly lower risk of brain swelling (risk ratio [RR]: 0.85, p = 0.03, I 2  = 21%, n = 1976) in patients receiving propofol than in those using volatile agents, without significant differences in surgical time or blood loss between the two groups. Moreover, propofol was associated with a lower intracranial pressure (ICP) (mean difference: -4.06 mmHg, p < 0.00001, I 2  = 44%, n = 409) as well as a lower risk of tachycardia (RR = 0.54, p = 0.005, I 2  = 0%, n = 822) and postoperative nausea/vomiting (PONV) (RR = 0.59, p = 0.002, I 2  = 19%, n = 1382). There were no significant differences in other recovery outcomes (e.g., extubation time), risk of bradycardia, hypertension, or hypotension between the two groups. Subgroup analysis indicated that propofol was not associated with a reduced risk of brain swelling when compared to individual volatile agents. Stratified by craniotomy indications, propofol reduced brain swelling in elective craniotomy, but not in emergency craniotomy (e.g., traumatic brain injury), when compared to volatile anesthetics.
Conclusions: By reviewing the available evidence, our results demonstrate the beneficial effects of propofol on the risk of brain swelling, ICP, PONV, and intraoperative tachycardia. In emergency craniotomy for traumatic brain injury and subarachnoid hemorrhage, brain swelling showed no significant difference between propofol and volatile agents. Further large-scale studies are warranted for verification.
Competing Interests: Declaration of Competing Interest None declared.
(Copyright © 2023 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: